Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Multi-Targeting Approach to Fight SARS-CoV-2 Attachment

3 Aug 2020

Abstract excerpt

The public health has declared an international state of emergency due to the spread of a new coronavirus (SARS-CoV-2) representing a real pandemic threat so that to find potential therapeutic agents is a dire need. To this aim, the SARS-CoV-2 spike (S) glycoprotein represents a crucial target for vaccines, therapeutic antibodies, and diagnostics. Since virus binding to ACE-2 alone could not be sufficient to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Toxin Mechanisms and Immunotoxins
Share to Immunotherapy and Immune Responses
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32850973
DOI: 10.3389/fmolb.2020.00186

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Multi-Targeting Approach to Fight SARS-CoV-2 AttachmentPMID 32850973Read ↗

More Is Always Better Than One: The N-Terminal Domain of the Spike Protein as Another Emerging Target for Hampering the SARS-CoV-2 Attachment to Host CellsSemantic proximity Read ↗

The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and AntibodiesSemantic proximity Read ↗

The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoVSemantic proximity Read ↗

The Role of the SARS-CoV-2 S-Protein Glycosylation in the Interaction of SARS-CoV-2/ACE2 and Immunological ResponsesSemantic proximity Read ↗

The N-glycosylation sites and Glycan-binding ability of S-protein in SARS-CoV-2 CoronavirusSemantic proximity Read ↗

SARS-CoV-2 Infects Human ACE2-Negative Endothelial Cells through an αvβ3 Integrin-Mediated Endocytosis Even in the Presence of Vaccine-Elicited Neutralizing AntibodiesSemantic proximity Read ↗

SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host CellsSemantic proximity Read ↗

Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitroSemantic proximity Read ↗

Structural Insights Into the Design of Peptide-based Drug or Diagnostic Reagent Antagonizing SARS-COV-2Semantic proximity Read ↗

Comprehensive role of SARS‐CoV‐2 spike glycoprotein in regulating host signaling pathwaySemantic proximity Read ↗

Significant role of host sialylated glycans in the infection and spread of severe acute respiratory syndrome coronavirus 2Semantic proximity Read ↗

The glycosylation in SARS-CoV-2 and its receptor ACE2Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.